Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)
Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of a course of injections containing
Poly-ICLC in patients with advanced solid tumors that can be easily and safely reached with a
needle.
Poly-ICLC is a compound that has been used to help the body in its fight against cancer.